Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17351
Country/Region: India
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,900,000 Additional Pipeline Funding: $100,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Health Systems Strengthening (OHSS) $142,500
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $1,757,500
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 604
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 150
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 15,009
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 3,752
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 15,613
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 3,902
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 15,613
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 3,902
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 15,613
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 3,902
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 57
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 14
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,207
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 304
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2017 6,248
KP_MAT Sex: Female 2017 252
KP_MAT Sex: Male 2017 5,996
KP_MAT Sum of Sex Disaggregates 2017 6,248
TX_CURR Aggregated Age/Sex: 15+ Female 2017 214
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,252
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,466
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,466
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,466
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 84
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,573
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,657
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,657
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 142
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 156
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 195
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 177
Cross Cutting Budget Categories and Known Amounts Total: $200,000
Human Resources for Health $50,000
Gender: Gender Equality $150,000
Changing harmful gender norms and promoting positive gender norms
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Implementation
Capacity building
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Monitoring and Evaluation